Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19

2Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Patients with hematologic malignancies have increased susceptibility to viral infections and suboptimal immunologic responses to current vaccines due to both disease-associated and therapy-related immune dysfunction. These considerations may impact the efficacy of emerging COVID-19 vaccines in this patient population as well and warrant the need to systematically study natural and vaccine-induced virus-specific immunity in these patients.

Cite

CITATION STYLE

APA

Dhodapkar, M. V., Dhodapkar, K. M., & Ahmed, R. (2021). Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19. Cancer Discovery, 2(1), 9–12. https://doi.org/10.1158/2643-3230.BCD-20-0177

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free